StockClub

Latest News

Seeking Alpha

JPMorgan Chase: Getting Paid 6.4% While Waiting For Lower Interest Rates

JPMorgan Chase delivered robust Q2 results, with net profit reaching $21.2B and EPS of $7.71, driven by strong non-interest revenue growth. JPM's preferred dividends remain well-covered, requiring jus

last month
OtherNewsfile Corp

CCOI DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Cogent Investors of Securities Class Action Lawsuit Deadline on September 21, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cogent To Contact Him Directly To Discuss Their Options If you purchased or acquired

last month
Newsfile Corp

ROSEN, A TOP RANKED LAW FIRM, Encourages DNOW Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - DNOW

New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DNOW Inc. (NYSE: DNOW) as of the August 5, 2025 r

last month
Seeking Alpha

BCV: Deep Discount And Another Payout Lift

The Bancroft Fund remains a 'Buy' due to an attractive discount, but it is quite a persistently deep discount, so no screaming bargain. BCV's portfolio is heavily weighted toward convertible securitie

last month
OtherForbes

There Will Be More ‘Outer Banks' On Netflix After Season 5, Kind Of

Outer Banks season 5 has arrived and ended the series on a rather conclusive note, indicating there won't be a secret sixth season to bring things back and undo the series finale. However, Outer Banks

last month
Seeking Alpha

Eli Lilly: Shaking Off Competition From The Dethroned Novo Nordisk

Eli Lilly has strengthened its global obesity drug market dominance, outpacing Novo Nordisk despite intensifying competition and pricing pressures. LLY's US market share has plateaued at 60–61%, but r

last month
EarningsSeeking Alpha

Nvidia's Real Test Comes After Earnings

Nvidia's Q2 consensus stands at $92.05 billion revenue and $2.09 EPS after eight consecutive quarters of beats. Q3 revenue expectations have climbed to $103.7 billion, making forward guidance more imp

last month
Sponsored
MacroForbes

No Deal: 50% Canadian Tariffs Implemented After ‘Unfair' Negotiations

"(Canadian negotiators) worked hard, in good faith, to defend the interests of Canadians throughout these negotiations up until the very last minute," Carney said. “However, last-minute changes in the

last month
OtherPRNewsWire

Primoris Services Corporation (PRIM) Investors: September 21, 2026, Deadline in Securities Fraud Class Action Lawsuit

Did you buy PRIM common stock between August 5, 2025 and June 22, 2026? Affected PRIM Investor Summary Who: Primoris Services Corporation (NYSE: PRIM) What: Securities fraud class action lawsuit filed

last month
OtherNewsfile Corp

ROSEN, SKILLED INVESTOR COUNSEL, Encourages UP Fintech Holding Limited Investors to Inquire About Securities Class Action Investigation - TIGR

New York, New York--(Newsfile Corp. - August 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of UP Fi

last month
OtherNewsfile Corp

EQPT DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds EquipmentShare.com (EQPT) Investors of Securities Class Action Lawsuit Deadline on September 21, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In EquipmentShare To Contact Him Directly To Discuss Their Options If you purchased or a

last month
AnalystSeeking Alpha

Rocket Lab: Mars Ambition & Growing Backlog Outweighs Delayed Neutron Timing (Rating Upgrade)

Rocket Lab Corporation's strategic acquisitions—Mynaric, Motiv Space Systems, and Iridium—imply their vertically integrated space design/manufacturing, launch, and application ambitions. This is on to

last month
EarningsMarketBeat

3 Stocks Came Roaring Back—Now They're Flashing Warning Signs

Markets have been on a wild ride this summer, with the S&P 500 finally making a new all-time high and several left-for-dead stocks showing new life in the second half of the year. But not all rallies

last month
Seeking Alpha

HYDB: Systematic High-Yield Bond ETF, Solid Strategy, Track Record, Dividend Yield

HYDB is a high-yield corporate bond index ETF. Its index is quite unique, focusing on high-yield bonds with above-average spreads for their credit quality. HYDB's strategy results in slightly higher d

last month
Sponsored
MacroThe Guardian

Canada vows ‘dollar for dollar' response as US puts 50% tariffs on some goods

Collapse of trade talks could lead to job losses, but biggest impact on traditional allies is expected to be political

last month
Seeking Alpha

StubHub: Still A Buy, Still Strong, Still Underrated

StubHub Holdings remains a strong buy at current levels, trading at just 8-9x forward FCF with a solid industry moat. STUB's Q2 2026 results showed 33% GMS growth, $106M adjusted EBITDA, and net lever

last month
M&AMarketBeat

Madison Air Solutions to Buy ebm-papst in $5.8B Deal, Expanding Global Airflow Reach

Madison Air Solutions NYSE: MAIR said it has signed an agreement to acquire ebm-papst, a Germany-based provider of high-performance airflow technology, in a transaction valued at $5.8 billion in total

last month
Seeking Alpha

CoreWeave's Economics Are Finally Starting To Work

CoreWeave's revenue surged 112% to $2.6 billion as backlog reached $104 billion and active power expanded to 1.5 GW. New contracts carry 5–10 percentage points higher margins, while CoreWeave raised G

last month
New York Post

Tesla feature at the center of nearly 3 million-vehicle recall

The US automaker said the recall covers imported and China-made Model 3, Model Y, Model S and Model X vehicles, according to notices filed with China's State Administration for Market Regulation.

last month
Seeking Alpha

Tempus AI: Winning With Precision Medicine

Tempus AI, Inc. made a timely move to acquire the Personalis cancer monitoring tests to advance AI-driven precision medicine. Recent cancer vaccine developments from Merck and Moderna reinforce the st

last month